News
$In8bio(INAB.US$ IN8bio Announces Clinical Update Demonstrating Continued Durable Complete Remission In 100% Of Evaluable Patients In Phase 1 Trial Of INB-100 In Leukemia Presented At The 65th American Society Of Hematology Annual Meeting
Benzinga· 2 mins ago
Benzinga· 2 mins ago
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment